Opportunity Information: Apply for RFA AT 23 006

This NIH funding opportunity (RFA-AT-23-006) supports the creation of research networks focused on understanding how music-based interventions (MBIs) work at a mechanistic level in two major health areas: pain and Alzheimers disease/Alzheimers disease related dementias (AD/ADRD). The emphasis is not simply on showing that music interventions help, but on building coordinated, multidisciplinary teams that can explain why and how they help, using rigorous biological, psychological, neurological, and behavioral science approaches. The networks are meant to lay the groundwork for stronger, more consistent future clinical research by developing shared research frameworks, aligning the field around common language, and generating early evidence that can lead to larger NIH-funded studies.

The award mechanism is a U24 cooperative agreement, meaning NIH expects to be actively involved in the funded networks rather than functioning as a hands-off funder. The FOA is labeled "clinical trial optional," which signals that applicants may include clinical trial activity if it fits the network goals, but it is not required. In practice, the program is designed to build infrastructure and collaboration capacity while also enabling small, targeted pilot projects that test new mechanistic hypotheses. Those pilots are intended to produce preliminary data, demonstrate feasibility, and sharpen measurement approaches so investigators are better positioned to compete for larger, later-stage NIH grants.

A central expectation is that each network will create a compelling, widely useful research framework that guides how music-based intervention studies should be designed in the targeted conditions. That includes adopting consistent terminology and a shared taxonomy, which is important in a field where "music therapy," "music medicine," "music listening," "active music-making," and other formats can be defined differently across disciplines and studies. By standardizing definitions and intervention descriptions, the networks help make results easier to compare, synthesize, and replicate across sites and populations, which is critical for building a credible evidence base.

Another major goal is to strengthen interdisciplinary collaboration. These networks are expected to bring together expertise that might otherwise remain siloed, such as neuroscientists, clinicians, music therapists, psychologists, pain researchers, dementia specialists, biostatisticians, bioengineers, and experts in digital health and wearable sensing. The FOA explicitly encourages activities that make collaboration real and sustained, including meetings, workshops, conferences, coordinated research collaborations, and structured exchanges of ideas such as visiting scientist arrangements and training opportunities. The overall intent is to create a durable community of practice that can collectively answer mechanistic questions that are too complex for single labs or single disciplines to tackle effectively.

The FOA also highlights the need to identify and advance strong mechanistic measures, outcomes, and biomarkers, along with novel technologies and methodologies that can move the field forward. For pain and AD/ADRD, this can include identifying which neural circuits, stress-related pathways, inflammatory markers, autonomic measures, cognitive endpoints, behavioral markers, or neuroimaging signatures best capture the mechanisms by which an MBI may influence symptoms, function, or disease-related outcomes. The networks are expected to help determine what to measure, how to measure it, and how to do so in a way that is feasible and meaningful in real-world clinical and community settings. This focus on measurement and methodology is meant to reduce inconsistency across studies and improve the interpretability of future trials.

Pilot projects are a key feature of the networks. Rather than funding only discussion and planning, the FOA anticipates that network-generated collaboration will lead to small, strategic pilots that address research gaps identified through network meetings and discussions. These pilots should test novel mechanistic hypotheses, refine intervention components, evaluate feasibility of measurement approaches, and generate preliminary data. The practical value is that pilot findings can de-risk future studies, clarify what outcomes and biomarkers are most informative, and provide the early evidence needed for competitive applications to larger NIH mechanisms.

Dissemination is not treated as an afterthought. The networks are expected to actively promote and sustain their scientific impact through publications and outreach, including research frameworks, common terminology documents, reviews, best-practice recommendations, and other communication strategies that help the broader field adopt what the network develops. The idea is that the network should produce field-shaping outputs that last beyond the award period, influencing how music-based intervention research is conducted, evaluated, and reported.

Eligibility is broad and includes many organization types across government, academia, nonprofit, and private sectors. Eligible applicants include state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses; and other categories. The FOA also calls out additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and certain tribal governments other than federally recognized. At the same time, non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined by NIH policy, are allowed, which can enable specific international collaborations when they are justified and structured within NIH rules.

Administratively, the sponsoring agency is the National Institutes of Health, the funding instrument is a cooperative agreement, and the activity category is health. The CFDA numbers listed are 93.213 and 93.866. The opportunity was created on 2022-10-17 and had an original closing date of 2023-01-10. The listing shows an award ceiling of $300,000, indicating an upper limit on award size as presented in the provided source data. Overall, the program is best understood as NIH support for network-based infrastructure plus targeted pilots, with the explicit purpose of accelerating high-quality mechanistic science around music-based interventions for pain and AD/ADRD and creating shared standards that make future clinical research stronger, more comparable, and more likely to translate into practice.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.866.
  • This funding opportunity was created on 2022-10-17.
  • Applicants must submit their applications by 2023-01-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $300,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AT 23 006

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Music Programs, Alzheimers Disease Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Previous opportunity: NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AT 23 006

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AT 23 006) also looked into and applied for these:

Funding Opportunity
USAID/Bangladesh Request for Information on USAID’s Accelerating Reductions in Adolescent Childbearing Apply for 72038823RFI00003

Funding Number: 72038823RFI00003
Agency: Bangladesh USAID-Dhaka
Category: Health
Funding Amount: Case Dependent
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed) Apply for PAR 23 039

Funding Number: PAR 23 039
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) Apply for PAR 22 248

Funding Number: PAR 22 248
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) Apply for PAR 22 252

Funding Number: PAR 22 252
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01) Apply for PAR 23 040

Funding Number: PAR 23 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) Apply for PA 23 044

Funding Number: PA 23 044
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed) Apply for PAR 23 033

Funding Number: PAR 23 033
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
Madagascar Urban Sanitation Project Addendum Apply for 7200AA21APS00004 687

Funding Number: 7200AA21APS00004 687
Agency: Madagascar USAID-Antananarivo
Category: Health
Funding Amount: $10,000,000
John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed) Apply for RFA MD 22 010

Funding Number: RFA MD 22 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) Apply for PAR 23 046

Funding Number: PAR 23 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) Apply for PAR 23 047

Funding Number: PAR 23 047
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed) Apply for RFA OD 22 025

Funding Number: RFA OD 22 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required) Apply for RFA OD 22 024

Funding Number: RFA OD 22 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required ) Apply for RFA OD 22 026

Funding Number: RFA OD 22 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed) Apply for RFA OD 22 023

Funding Number: RFA OD 22 023
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limpopo Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 LIMPOPO

Funding Number: RFI 674 23 LIMPOPO
Agency: South Africa USAID-Pretoria
Category: Health
Funding Amount: Case Dependent
Free State Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 FREESTATE

Funding Number: RFI 674 23 FREESTATE
Agency: South Africa USAID-Pretoria
Category: Health
Funding Amount: Case Dependent
North West Province Orphans and Vulnerable Children Activity Apply for RFI 674 23 NORTHWEST

Funding Number: RFI 674 23 NORTHWEST
Agency: South Africa USAID-Pretoria
Category: Health
Funding Amount: Case Dependent
Cooperative Centers on Human Immunology (U19 Clinical Trial Optional) Apply for RFA AI 22 069

Funding Number: RFA AI 22 069
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) Apply for PAR 24 022

Funding Number: PAR 24 022
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 23 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: